Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/2/09 → 4/2/12 |
Funding
- Kyowa Hakko Kirin Pharma, Inc. (BIW-8962-001)
Prot# BIW-8962-001: Open-Label, Multi-Center, Dose Escalation, Phase 1/2 Study of Anti-GM2 Ganglioside Monoclonal Antibody BIW-8962 as Monotherapy in Subjects with Previously Treated Multiple Myeloma
- Singhal, Seema (PD/PI)
Project: Research project